Effect of ertugliflozin on renal function and cardiovascular outcomes in patients with type 2 diabetes mellitus: A systematic review and meta-analysis

The global prevalence of type 2 diabetes mellitus (T2DM) is growing yearly. The efficacy of ertugliflozin (ERT), a recently licensed anti-diabetic drug, has been widely reported. However, additional evidence-based data is required to ensure its safety. In particular, convincing evidence on the effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Qian, Zou, Shupeng, Feng, Chengyang, Xu, Chan, Zhao, Yazheng, Shi, Xuan, Sun, Minghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997778/
https://www.ncbi.nlm.nih.gov/pubmed/36897734
http://dx.doi.org/10.1097/MD.0000000000033198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997778/
https://www.ncbi.nlm.nih.gov/pubmed/36897734
http://dx.doi.org/10.1097/MD.0000000000033198

Ejemplares similares